Epcoritamab as Consolidative Therapy for Waldenstr(SqrRoot)(Delta)m Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi)

​ Conditions: Waldenstrom Macroglobulinemia

Interventions: Drug: epcoritamab

Sponsors: National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting Conditions: Waldenstrom Macroglobulinemia
Interventions: Drug: epcoritamab
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting